FOLH1 and prostate cancer: Prostate specific membrane antigen (PSMA) – specific ligand was used to actively target the nanoparticles to cancer cells. Increased ROS generation in prostate cancer cells in cell culture and tumor growth inhibition was shown in athymic BALB/c mice implanted with PSMA-producing LNCaP cell tumors